Search - tctmd.com

Displaying 1 - 20 of 35

Sort: Relevancy | Date

News Daily News

ISCHEMIA: No Clinical Event Reduction With Invasive Strategy in CTO Patients

Michael O'Riordan

March 26, 2025

News Daily News

ORBITA-STAR Highlights Variability in Symptom Changes Post-PCI

Michael O'Riordan

July 01, 2024

News Daily News

Pay Now, Save Later: Intracoronary Imaging for PCI Cost-effective Over Lifetime

Yael L. Maxwell

March 18, 2024

News Conference News AHA 2023

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

Michael O'Riordan

November 11, 2023

News Daily News

New AHA/ACC Performance and Quality Metrics for Coronary Revascularization

Michael O'Riordan

July 28, 2023

News Daily News

More Angina Relief With Complete Revascularization in Stable CAD: ISCHEMIA

Michael O'Riordan

July 18, 2023

News Daily News

Many STEMI Patients Not Treated Within National Time Goals

Michael O'Riordan

November 15, 2022

News Daily News

PCI and CABG Are Complementary Options for Left Main CAD, Say Experts

Michael O'Riordan

April 27, 2022

News Conference News ACC 2022

No Difference in 1-Year QoL Between FFR-Guided PCI and CABG: FAME-3

Michael O'Riordan

April 13, 2022

News Daily News

Optimal Medical Therapy for Stable Angina: Which Drugs? How Long?

Michael O'Riordan

January 25, 2022

News Conference News TCT 2021

Good Early Outcomes With PCI in Complex Patients Unsuited to Surgery: OPTIMUM

Michael O'Riordan

November 04, 2021

News Conference News TCT 2021

FAME 3: PCI Fails to Demonstrate Noninferiority to Surgery in Three-Vessel CAD

Michael O'Riordan

November 04, 2021

News Daily News

Women Stand to Gain the Most From Standardized STEMI Protocols

Michael O'Riordan

September 30, 2021

News Conference News ESC 2021

FFR During Angiogram Not Beneficial in Chest Pain Patients: RIPCORD 2

Michael O'Riordan

August 29, 2021

News Opinion Conversations in Cardiology

Conversations in Cardiology: In the ISCHEMIA Era, What Role for FFR?

January 02, 2020

News

Analysis Hints at Survival Benefit With Revascularization in Stable Patients With Myocardial Ischemia

Michael O'Riordan

September 24, 2019

News Conference News TCT 2018

CorMicA Offers Glimmer of Hope for Testing, Treating Angina Without Obstructive CAD

Shelley Wood

September 26, 2018

News Conference News EuroPCR 2018

ORBITA Deep Dive Highlights Treatment Choices, Social Media, and Ethics

Michael O'Riordan

May 31, 2018

News Conference News EuroPCR 2018

Modest Benefit of PCI Over Medical Therapy in Patients With ‘Grey Zone’ FFR Lesions

Michael O'Riordan

May 23, 2018

News Daily News

Uncomplicated TLR After PCI Linked With Worse Mortality

Michael O'Riordan

April 20, 2018

Advertisement

ISCHEMIA: No Clinical Event Reduction With Invasive Strategy in CTO Patients

ORBITA-STAR Highlights Variability in Symptom Changes Post-PCI

Pay Now, Save Later: Intracoronary Imaging for PCI Cost-effective Over Lifetime

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

New AHA/ACC Performance and Quality Metrics for Coronary Revascularization

More Angina Relief With Complete Revascularization in Stable CAD: ISCHEMIA

Many STEMI Patients Not Treated Within National Time Goals

PCI and CABG Are Complementary Options for Left Main CAD, Say Experts

No Difference in 1-Year QoL Between FFR-Guided PCI and CABG: FAME-3

Optimal Medical Therapy for Stable Angina: Which Drugs? How Long?

Good Early Outcomes With PCI in Complex Patients Unsuited to Surgery: OPTIMUM

FAME 3: PCI Fails to Demonstrate Noninferiority to Surgery in Three-Vessel CAD

Women Stand to Gain the Most From Standardized STEMI Protocols

FFR During Angiogram Not Beneficial in Chest Pain Patients: RIPCORD 2

Conversations in Cardiology: In the ISCHEMIA Era, What Role for FFR?

Analysis Hints at Survival Benefit With Revascularization in Stable Patients With Myocardial Ischemia

CorMicA Offers Glimmer of Hope for Testing, Treating Angina Without Obstructive CAD

ORBITA Deep Dive Highlights Treatment Choices, Social Media, and Ethics

Modest Benefit of PCI Over Medical Therapy in Patients With ‘Grey Zone’ FFR Lesions

Uncomplicated TLR After PCI Linked With Worse Mortality

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content